Home/Filings/8-K/0001193125-24-065935
8-K//Current report

PhaseBio Pharmaceuticals Inc 8-K

Accession 0001193125-24-065935

CIK 0001169245operating

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:34 PM ET

Size

6.1 MB

Accession

0001193125-24-065935